blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1907399

EP1907399 - 5,6-DI-SUBSTITUTED OXADIAZOLOPYRAZINES AND THIADIAZOLOPYRAZINES AS CXC-CHEMOKINE RECEPTOR LIGANDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.09.2011
Database last updated on 16.11.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Schering Corporation
2000 Galloping Hill Road
Kenilworth, NJ 07033-0530 / US
[2008/15]
Inventor(s)01 / PURAKKATTLE, Biju, J.
2 Wyndham Way
Piscataway, New Jersey 08854 / US
 [2008/26]
Former [2008/15]01 / PURAKKATTLE, Biju, J.
55 Country Club Lane
Scotch Plains, NJ 07076 / US
Representative(s)Hussain, Deeba
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2010/40]Hussain, Deeba
Merck & Co., Inc. Hertford Road Hoddesdon
Hertfordshire EN11 9BU / GB
Former [2008/34]UEXKÜLL & STOLBERG
Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Former [2008/15]UEXKÜLL & STOLBERG
Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Application number, filing date06785619.527.06.2006
[2008/15]
WO2006US24908
Priority number, dateUS20050695162P29.06.2005         Original published format: US 695162 P
[2008/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007005403
Date:11.01.2007
Language:EN
[2007/02]
Type: A1 Application with search report 
No.:EP1907399
Date:09.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 11.01.2007 takes the place of the publication of the European patent application.
[2008/15]
Type: B1 Patent specification 
No.:EP1907399
Date:27.10.2010
Language:EN
[2010/43]
Search report(s)International search report - published on:EP11.01.2007
ClassificationIPC:C07D498/04, C07D513/04, A61K31/41, A61P11/06, A61P29/00, A61P35/00
[2008/15]
CPC:
C07D513/04 (EP,US); A61P1/00 (EP); A61P1/02 (EP);
A61P1/04 (EP); A61P1/16 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P11/08 (EP); A61P11/14 (EP);
A61P13/12 (EP); A61P15/06 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P17/04 (EP); A61P17/06 (EP);
A61P17/10 (EP); A61P19/02 (EP); A61P19/06 (EP);
A61P19/10 (EP); A61P21/00 (EP); A61P25/00 (EP);
A61P25/04 (EP); A61P25/08 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P31/04 (EP);
A61P31/12 (EP); A61P33/06 (EP); A61P35/00 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P7/02 (EP); A61P9/00 (EP); A61P9/10 (EP);
C07F9/6561 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/15]
Extension statesAL24.01.2008
BA24.01.2008
HR24.01.2008
MK24.01.2008
RS24.01.2008
TitleGerman:5,6-DISUBSTITUIERTE OXADIAZOLOPYRAZINE UND THIADIAZOLOPYRAZINE ALS LIGANDEN DES CXC-CHEMOKINREZEPTORS[2008/15]
English:5,6-DI-SUBSTITUTED OXADIAZOLOPYRAZINES AND THIADIAZOLOPYRAZINES AS CXC-CHEMOKINE RECEPTOR LIGANDS[2008/15]
French:OXADIAZOLOPYRAZINES 5,6-DI-SUBSTITUÉES ET THIADIAZOLOPYRAZINES COMME LIGANDS RÉCEPTEURS DE CXC-CHIMIOKINE[2008/15]
Entry into regional phase24.01.2008National basic fee paid 
24.01.2008Designation fee(s) paid 
24.01.2008Examination fee paid 
Examination procedure24.01.2008Examination requested  [2008/15]
09.06.2008Despatch of a communication from the examining division (Time limit: M06)
19.12.2008Reply to a communication from the examining division
11.03.2009Despatch of a communication from the examining division (Time limit: M06)
21.09.2009Reply to a communication from the examining division
05.05.2010Communication of intention to grant the patent
19.08.2010Fee for grant paid
19.08.2010Fee for publishing/printing paid
Opposition(s)28.07.2011No opposition filed within time limit [2011/40]
Fees paidRenewal fee
18.03.2008Renewal fee patent year 03
05.06.2009Renewal fee patent year 04
31.03.2010Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.10.2010
BE27.10.2010
CY27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
HU27.10.2010
LT27.10.2010
LV27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
TR27.10.2010
BG27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
IE27.06.2011
LU27.06.2011
CH30.06.2011
LI30.06.2011
MC30.06.2011
[2013/45]
Former [2013/44]AT27.10.2010
BE27.10.2010
CY27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
LT27.10.2010
LV27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
TR27.10.2010
BG27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
IE27.06.2011
LU27.06.2011
CH30.06.2011
LI30.06.2011
MC30.06.2011
Former [2013/26]AT27.10.2010
BE27.10.2010
CY27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
LT27.10.2010
LV27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
IE27.06.2011
LU27.06.2011
CH30.06.2011
LI30.06.2011
MC30.06.2011
Former [2013/25]AT27.10.2010
BE27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
LT27.10.2010
LV27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
IE27.06.2011
LU27.06.2011
CH30.06.2011
LI30.06.2011
MC30.06.2011
Former [2013/21]AT27.10.2010
BE27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
LT27.10.2010
LV27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
IE27.06.2011
CH30.06.2011
LI30.06.2011
MC30.06.2011
Former [2012/20]AT27.10.2010
BE27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
LT27.10.2010
LV27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
IE27.06.2011
CH30.06.2011
LI30.06.2011
Former [2011/38]AT27.10.2010
BE27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
FI27.10.2010
LT27.10.2010
LV27.10.2010
PL27.10.2010
RO27.10.2010
SE27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
Former [2011/30]AT27.10.2010
BE27.10.2010
FI27.10.2010
LT27.10.2010
LV27.10.2010
SE27.10.2010
SI27.10.2010
BG27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
Former [2011/23]FI27.10.2010
LT27.10.2010
LV27.10.2010
IS27.02.2011
Former [2011/19]LT27.10.2010
Cited inInternational search[A]WO0179209  (WARNER LAMBERT CO [US], et al) [A] 62 * claim 1 *;
 [DA]WO2004011418  (SCHERING CORP [US], et al) [DA] 1-80 * claim 1 *;
 [A]EP1529531  (4SC AG [DE]) [A] 1-80* paragraph [0001]; claim 1 *;
 [X]WO2005051974  (UNIV CALIFORNIA [US], et al) [X] 1-61 * page 50, line 15 - line 25; claims 54,58,62 *;
 [PA]WO2006044402  (COMPASS PHARMACEUTICALS LLC [US], et al) [PA] 1-72 * claim 1 *;
 [X]  - STARCHENKOV I B ET AL, "CHEMISTRY OF FURAZANOÄ3,4-BÜPYRAZINES 3. METHOD FOR THE SYNTHESIS OF 5,6-DISUBSTITUTED FURAZANOÄ3,4-BÜPYRAZINES", CHEMISTRY OF HETEROCYCLIC COMPOUNDS (A TRANSLATION OF KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII), PLENUM PRESS CO., NEW YORK, NY, US, (1997), vol. 33, no. 10, ISSN 0009-3122, pages 1219 - 1233, XP009025968 [X] 1-61 * Table 2, L, LI, LII, LIII, LV, LVI, LVIII-LXIII, LXX-LXXIV, LXXVI-CIII, CX; CXI *

DOI:   http://dx.doi.org/10.1007/BF02256764
 [X]  - FERNANDEZ E ET AL, "Solid-phase versus solution synthesis of asymmetrically disubstituted furazano[3,4-b]pyrazines", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, NL, (20020701), vol. 43, no. 27, ISSN 0040-4039, pages 4741 - 4745, XP004365869 [X] 1-61 * Compounds of the general formulae i, III, IV and v;; examples 1,2; table 1 *

DOI:   http://dx.doi.org/10.1016/S0040-4039(02)00913-9
by applicantWO0179209
 WO02083624
 WO2004011418
 US2004106794
 EP1529531
 WO2005051974
 WO2006044402
    - OPPENHEIM ET AL., ANNU. FEV. IMMUNOL., (1991), vol. 9, page 617
    - SEITZ ET AL., J. CLIN. INVEST., (1991), vol. 87, page 463
    - MILLER ET AL., AM. REV. RESPIR. DIS., (1992), vol. 146, no. 427
    - DONNELY ET AL., LANCET, (1993), vol. 341, page 643
    - INOUE ET AL., CLIN CANCER RES, (2000), vol. 6, pages 2104 - 2119
    - YONEDA, J NAT CANCER INST, (1998), vol. 90, pages 447 - 454
    - ARENBERG ET AL., J CLIN INVEST, (1996), vol. 97, pages 2792 - 2802
    - ARENBERG ET AL., J CLIN INVEST, (1998), vol. 102, pages 465 - 72
    - HAGHNEGAHDAR ET AL., J. LEUKOC BIOLOGY, (2000), vol. 67, pages 53 - 62
    - STARCHENKOV ET AL., "Chemistry of Furazano[3,4-b]pyrazines, 3. Method for the Synthesis of 5,6-disubstituted Furazano[3,4-b]pyrazines", CHEMISTRY OF HETEROCYCLIC COMPOUNDS, (1997), vol. 33, no. 10, pages 1219 - 1233
    - FERNANDEZ ET AL., "Solid-phase versus solution synthesis of asymmetrically disubstituted furazano[3,4-b]pyrazines", TETRAHEDRON LETTERS, (2002), vol. 43, pages 4741 - 4745
    - M. CAIRA ET AL., J. PHARMACEUTICAL SCI., (2004), vol. 93, no. 3, pages 601 - 611
    - E. C. VAN TONDER ET AL., AAPS PHARMSCITECH., (2004), vol. 12
    - A. L. BINGHAM ET AL., CHEM. COMMUN., (2001), pages 603 - 604
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.